Factors Associated With the Discussion of Fertility Preservation in a Cohort of 1,357 Young Breast Cancer Patients Receiving Chemotherapy.
breast cancer
chemotherapy
discussion
fertility preservation
oncofertility
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2021
2021
Historique:
received:
28
04
2021
accepted:
31
08
2021
entrez:
15
10
2021
pubmed:
16
10
2021
medline:
16
10
2021
Statut:
epublish
Résumé
Female breast cancer (BC) patients exposed to gonadotoxic chemotherapy are at risk of future infertility. There is evidence of disparities in the discussion of fertility preservation for these patients. The aim of the study was to identify factors influencing the discussion of fertility preservation (FP). We analyzed consecutive BC patients treated by chemotherapy at Institut Curie from 2011-2017 and aged 18-43 years at BC diagnosis. The discussion of FP was classified in a binary manner (discussion/no discussion), based on mentions present in the patient's electronic health record (EHR) before the initiation of chemotherapy. The associations between FP discussion and the characteristics of patients/tumors and healthcare practitioners were investigated by logistic regression analysis. The median age of the 1357 patients included in the cohort was 38.7 years, and median tumor size was 30.3 mm. The distribution of BC subtypes was as follows: 702 luminal BCs (58%), 241 triple-negative breast cancers (TNBCs) (20%), 193 HER2 FP discussion rates are low and are influenced by patient and physician characteristics. There is therefore room for improvement in the promotion and systematization of FP discussion.
Identifiants
pubmed: 34650912
doi: 10.3389/fonc.2021.701620
pmc: PMC8507557
doi:
Types de publication
Journal Article
Langues
eng
Pagination
701620Informations de copyright
Copyright © 2021 Hours, Toussaint, De Castelbajac, Sautter, Borghese, Frank, Coussy, Laas, Grandal, Dumas, Daoud, Guerin, Balezeau, Feron, Fourchotte, Kirova, Lerebours, Pierga, Guillot, Santulli, Grynberg, Sonigo, Reyrat, Soibinet-Oudot, Reyal and Hamy.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Fertil Steril. 2014 Mar;101(3):633-4
pubmed: 24559617
Breast. 2007 Dec;16 Suppl 2:S175-81
pubmed: 17804236
Ann Oncol. 2020 Apr;31(4):541-542
pubmed: 32085890
Hum Reprod Update. 2014 Sep-Oct;20(5):759-74
pubmed: 24833728
Hum Reprod. 1992 Nov;7(10):1342-6
pubmed: 1291557
Fertil Steril. 2011 May;95(6):1932-6
pubmed: 21371704
Bull Cancer. 2016 Nov;103(11):949-950
pubmed: 27816168
Histopathology. 1991 Nov;19(5):403-10
pubmed: 1757079
J Am Med Inform Assoc. 2014 Oct;21(e2):e332-40
pubmed: 24780721
JAMA Netw Open. 2020 Jul 1;3(7):e2010806
pubmed: 32678451
Fertil Steril. 2017 Jan;107(1):243-252.e5
pubmed: 27887709
J Gynecol Obstet Biol Reprod (Paris). 2013 May;42(3):246-51
pubmed: 23453919
JAMA Oncol. 2021 Jan 01;7(1):86-91
pubmed: 33211089
Cancer. 2012 Mar 15;118(6):1710-7
pubmed: 21887678
BMJ Open Qual. 2018 Aug 10;7(3):e000088
pubmed: 30167470
Arch Pathol Lab Med. 2014 Feb;138(2):241-56
pubmed: 24099077
J Clin Oncol. 2005 Feb 1;23(4):766-73
pubmed: 15681520
J Clin Oncol. 2018 Jul 1;36(19):1994-2001
pubmed: 29620997
Int Surg. 1996 Jan-Mar;81(1):57-60
pubmed: 8803708
JCO Clin Cancer Inform. 2019 Oct;3:1-12
pubmed: 31626565
Semin Oncol. 2009 Jun;36(3):237-49
pubmed: 19460581
Br J Cancer. 2013 Apr 30;108(8):1602-15
pubmed: 23579214
BMC Cancer. 2015 Aug 05;15:572
pubmed: 26239242
J Oncol Pract. 2010 Jul;6(4):195-7
pubmed: 21037871
JAMA Netw Open. 2019 Nov 1;2(11):e1914511
pubmed: 31693121
J Adolesc Young Adult Oncol. 2019 Apr;8(2):197-204
pubmed: 30676852
J Clin Oncol. 2005 Aug 1;23(22):5155-65
pubmed: 16051957
Fertil Steril. 2010 Oct;94(5):1652-6
pubmed: 19945099